Evidence map›Paper›PMID 37371429›Full record

ArticleBrain sciences2023

A Potential Biomarker of Brain Activity in Autism Spectrum Disorders: A Pilot fNIRS Study in Female Preschoolers.

Elena Scaffei, Raffaele Mazziotti, Eugenia Conti, Valeria Costanzo, Sara Calderoni, Andrea Stoccoro, Claudia Carmassi, Raffaella Tancredi, Laura Baroncelli, Roberta Battini

2 registry-linked trialsAbstract read
In one paragraph

Article in Brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06292884 unknown statusnot on this map

Establishing Novel Functional Biomarkers for Creatine Deficiency Syndromes

TypeobservationalSponsorIRCCS Fondazione Stella MarisRan2023 to 2025Enrolled30ConditionsCreatine Deficiency, X-linked, Creatine Deficiency Syndrome Due to Gamt Deficiency
NCT06293027 unknown statusnot on this map

Establishing Novel Functional Biomarkers for Fragile X Syndrome

TypeobservationalSponsorIRCCS Fondazione Stella MarisRan2023 to 2025Enrolled40ConditionsFragile X Syndrome
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elena ScaffeiDepartment of Neuroscience, Psychology, Drug Research and Child Health NEUROFARBA, University of Florence, 50135 Florence, Italy.ORCID 0000-0002-7941-362X
Raffaele MazziottiIRCCS Stella Maris Foundation, Viale del Tirreno, 56128 Pisa, Italy.
Eugenia ContiIRCCS Stella Maris Foundation, Viale del Tirreno, 56128 Pisa, Italy.
Valeria CostanzoIRCCS Stella Maris Foundation, Viale del Tirreno, 56128 Pisa, Italy.
Sara CalderoniIRCCS Stella Maris Foundation, Viale del Tirreno, 56128 Pisa, Italy.ORCID 0000-0002-6250-5739
Andrea StoccoroDepartment of Translational Research and of New Surgical and Medical Technologies, University of Pisa, 56100 Pisa, Italy.ORCID 0000-0002-6768-8466
Claudia CarmassiDepartment of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy.ORCID 0000-0002-3662-8073
Raffaella TancrediIRCCS Stella Maris Foundation, Viale del Tirreno, 56128 Pisa, Italy.
Laura BaroncelliInstitute of Neuroscience, National Research Council, Via Moruzzi 1, 56124 Pisa, Italy.ORCID 0000-0001-6739-2860
Roberta BattiniIRCCS Stella Maris Foundation, Viale del Tirreno, 56128 Pisa, Italy.ORCID 0000-0002-7889-1355

Funding

Fondazione Stella Maris Ricerca Corrente RC 2021Fondazione Umberto Veronesi Fondazione Umberto VeronesiTelethon Foundation Telethon GP19177University of Pisa Bando PRA-Progetti di Ricerca di Ateneo" (Institutional Research Grants) 2020-2021
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) refers to a neurodevelopmental condition whose detection still remains challenging in young females due to the heterogeneity of the behavioral phenotype and the capacity of camouflage. The availability of quantitative biomarkers to assess brain function may support in the assessment of ASD. Functional Near-infrared Spectroscopy (fNIRS) is a non-invasive and flexible tool that quantifies cortical hemodynamic responses (HDR) that can be easily employed to describe brain activity. Since the study of the visual phenotype is a paradigmatic model to evaluate cerebral processing in many neurodevelopmental conditions, we hypothesized that visually-evoked HDR (vHDR) might represent a potential biomarker in ASD females. We performed a case-control study comparing vHDR in a cohort of high-functioning preschooler females with ASD (fASD) and sex/age matched peers. We demonstrated the feasibility of visual fNIRS measurements in fASD, and the possibility to discriminate between fASD and typical subjects using different signal features, such as the amplitude and lateralization of vHDR. Moreover, the level of response lateralization was correlated to the severity of autistic traits. These results corroborate the cruciality of sensory symptoms in ASD, paving the way for the validation of the fNIRS analytical tool for diagnosis and treatment outcome monitoring in the ASD population.

Indexed as

autismbiomarkerfemalefNIRSpreschoolersvisual physiology

Identifiers

PMID37371429
PMCPMC10296408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.